INTELLIA THERAPEUTICS INC's ticker is and the CUSIP is 45826J905. A total of 4 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $904,332 | -42.5% | 28,600 | -25.9% | 0.00% | -100.0% |
| Q2 2023 | $1,574,108 | -30.5% | 38,600 | -36.5% | 0.00% | 0.0% |
| Q1 2023 | $2,266,016 | +145.1% | 60,800 | +129.4% | 0.00% | – |
| Q4 2022 | $924,585 | -70.5% | 26,500 | -52.7% | 0.00% | -100.0% |
| Q3 2022 | $3,134,000 | +26.2% | 56,000 | +16.7% | 0.00% | 0.0% |
| Q2 2022 | $2,484,000 | – | 48,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 24,800 | $784,176 | 0.00% |
| SIMPLEX TRADING, LLC | 16,700 | $528 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 28,600 | $904,332 | 0.00% |